FDA issues fewer safety, quality citations (USA Today)
The nation's top food and drug regulator is citing fewer companies for poor quality or safety standards despite a relatively constant number of violations by companies, a congressional report says.

FDA Announces New Initiative To Modernize The Regulation Of Clinical Trials And Bioresearch Monitoring (Medical News Today)
The Food and Drug Administration (FDA) today announced a series of new policy and regulatory developments to strengthen the Agency's oversight and protection of patients in clinical trials and the integrity of resulting data in an effort to modernize the agency's approach to bioresearch monitoring as part of the Critical Path Initiative. [click link for full article]

A Federal Blight for Cherry Farmers (BusinessWeek Online via Yahoo! UK & Ireland Finance)
The FDA's warning letters to cherry farmers about health claims posted on their Web sites have troubling legal implications